SCHEMBL6327399

SCHEMBL6327399

COc1ccc(-c2sc(-c3ccc(SC(C)(C)C(=O)O)cc3)nc2C(=O)Nc2ccc(Cl)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.47
▸ LMNA P02545 5/20 0.45
▸ POLB P06746 1/20 0.45
▸ RXFP1 Q9HBX9 1/20 0.45
▸ MAPT P10636 4/20 0.45
▸ XDH P47989 1/20 0.44
▸ STAT3 P40763 1/20 0.44
▸ KMT2A Q03164 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ PTGDR2 Q9Y5Y4 1/20 0.43
▸ SLC22A12 Q96S37 1/20 0.42
▸ PPARA Q07869 4/20 0.41
▸ TP53 P04637 1/20 0.41
▸ CNR1 P21554 1/20 0.41
▸ AURKA O14965 2/20 0.41
▸ PPARD Q03181 2/20 0.41
▸ MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6328035 1.00 ALOX5 (0.47) ALOX5LMNAPOLBRXFP1MAPT
SCHEMBL6330961 0.95 STAT3 (0.47) ALOX5LMNAPOLBMAPTSTAT3
SCHEMBL6326299 0.94 XDH (0.47) LMNAPOLBMAPTXDHKMT2A
SCHEMBL6327314 0.92 TP53 (0.47) ALOX5LMNAMAPTSTAT3KMT2A
SCHEMBL6326381 0.91 TP53 (0.45) ALOX5LMNARXFP1MAPTSTAT3
SCHEMBL6328143 0.91 PPARG (0.47) MAPTXDHSTAT3KMT2ASMN1; SMN2
SCHEMBL6336676 0.91 SLC22A12 (0.44) ALOX5LMNAPOLBMAPTSTAT3
SCHEMBL6328043 0.90 STAT3 (0.47) LMNARXFP1MAPTSTAT3KMT2A
SCHEMBL6335297 0.90 XDH (0.46) LMNAPOLBMAPTXDHKMT2A
SCHEMBL6327984 0.90 PPARA (0.54) MAPTSTAT3KMT2ASMN1; SMN2PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014805-A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity BAYER PHARMACEUTICALS CORPORATION 2005-01-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014805-A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity GPR119, EGLN3, PC ALOX5 612/4885LMNA 2130/4885POLB 3979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback